Barclays Maintains an 'Equalweight' on Kindred Healthcare (KND); Initial 2011 Guidance - RUG-IV Better than Expected
Tweet Send to a Friend
Barclays maintains an 'Equalweight' on Kindred Healthcare (NYSE: KND), PT $15.
Barclays analyst says, "KND provided initial 2011 EPS guidance ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "KND provided initial 2011 EPS guidance ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
